Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06817915
What this trial is testing

This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Johannes Schiefelbein 100
Large-scale testing (Phase 3)Study completedNCT04864834
What this trial is testing

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Sandoz 485
Testing effectiveness (Phase 2)UnknownNCT05290948
What this trial is testing

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Who this might be right for
Macular Edema
Shahid Beheshti University of Medical Sciences 57
Testing effectiveness (Phase 2)Study completedNCT06176963
What this trial is testing

Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Who this might be right for
Neovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion
Samsung Bioepis Co., Ltd. 34
Not applicableStudy completedNCT04084587
What this trial is testing

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Macular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more
University of Modena and Reggio Emilia 24
Not applicableStudy completedNCT03092492
What this trial is testing

AMD Ryan Initiative Study (ARIS)

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 26
Post-approval studies (Phase 4)Study completedNCT03383328
What this trial is testing

Study for Optimizing Anti-inflammatory Prophylaxis

Who this might be right for
Postoperative Cystoid Macular EdemaIrvine-Gass Syndrome
Line Kessel 470
Not applicableUnknownNCT02328209
What this trial is testing

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Mie University 50
Not applicableStudy completedNCT02255981
What this trial is testing

Efficacy of Acupuncture in Macular Diseases

Who this might be right for
Age-related Macular DegenerationStargardt DiseaseMacular Dystrophy
Escuela Neijing 33
Not applicableStudy completedNCT02956330
What this trial is testing

Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Clearside Biomedical, Inc. 20
Large-scale testing (Phase 3)Study completedNCT01170767
What this trial is testing

French Evaluation Group Avastin Versus Lucentis

Who this might be right for
Age Related Macular Degeneration
Hospices Civils de Lyon 501
Large-scale testing (Phase 3)Study completedNCT03677934
What this trial is testing

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Hoffmann-La Roche 415
Large-scale testing (Phase 3)Study completedNCT04597632
What this trial is testing

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 248
Testing effectiveness (Phase 2)Looking for participantsNCT07547228
What this trial is testing

PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Intra-IMMUSG Pte Ltd 15
Not applicableStudy completedNCT01080898
What this trial is testing

Evaluation of Optical Coherence Tomography.

Who this might be right for
Age-Related Macular DegenerationChoroidal Vessels; Anastomosis
Assistance Publique - Hôpitaux de Paris 151
Early research (Phase 1)Study completedNCT01941082
What this trial is testing

RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Hoffmann-La Roche 24
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT06184360
What this trial is testing

Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 2,079
Post-approval studies (Phase 4)Study completedNCT01972789
What this trial is testing

Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)

Who this might be right for
Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD
Novartis Pharmaceuticals 349
Testing effectiveness (Phase 2)Looking for participantsNCT07215390
What this trial is testing

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 240
Next Page